Aqualung Therapeutics
Tucson
About Aqualung Therapeutics
Aqualung Therapeutics (Aqualung Therapeutics Corporation) leadership are experienced academic leaders, entrepreneurs and translational scientists with expertise in Precision Medicine, who are exploring NAMPT as a key target and novel diagnostic in acute and chronic lung inflammatory disorders. As an organization they are committed to finding novel targets in the treatment of respiratory diseases. Their team is highly skilled at clinical development and they are working collaboratively with the FDA to ensure both acute and chronic respiratory diseases that have significant unmet medical need receive priority review.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $22.3M
- Funding stage: Seed
- Last round: Seed (Apr 2023)
- Website: aqualungtherapeutics.com
- Phone: 312-618-7337
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/aqualung-therapeutics-87006 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.